Navigation Links
TorreyPines Therapeutics Reports Third Quarter 2007 Results
Date:11/14/2007

and pharmacokinetics of tezampanel

given once-daily for four consecutive days. Data from this multiple

dose trial are intended to support the continued development of

tezampanel for the treatment of migraine, as well as allow TorreyPines

to consider expanding the development of tezampanel into additional

chronic pain conditions.

-- Completed a Phase I multiple-dose clinical trial of NGX267 in

development for cognitive impairment associated with schizophrenia

(CIAS). NGX267 was found to be safe and well-tolerated. The clinical

trial also demonstrated that NGX267 increases salivary flow, which may

be beneficial in treating xerostomia, or dry mouth.

-- Extended the genetics discovery collaboration with Eisai Co., Ltd.

This agreement focuses on the discovery of Alzheimer's disease targets

using whole-genome family-based association screening. Under terms of

the agreement, TorreyPines received an upfront payment and continued

research funding in support of the program for an additional year.

Financial Results

Revenue for the three month period ended September 30, 2007 was $2.5 million compared to revenue of $2.5 million for the same period in 2006. Operating expenses for the quarter ended September 30, 2007 were $9.5 million, with $8.2 million attributable to research and development. This compares to operating expenses of $5.2 million and research and development expenses of $4.5 million for the same period last year. The Company reported a net loss for the quarter ended September 30, 2007 of $6.8 million compared to a net loss of $2.7 million for the same period last year.

Revenue for the nine month period ended September 30, 2007 was $7.4 million compared to revenue of $7.4 million for the same period in 2006. Operating expenses for the nine month period were $24.6 million, with $20.4 million attributabl
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
2. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
3. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
4. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
5. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... NY (PRWEB) May 20, 2013 With bed ... Products said that although bed bugs need to be eliminated, ... will not compromise a person's health. And so to help ... how to get rid of bed bugs without ... non-pesticide bed bug spray it called Bed Bug Bully. , ...
(Date:5/20/2013)... Mass. , May 20, 2013   Flexion ... Frederick W. Driscoll to its management ... than 30 years of financial management experience with biotechnology ... Flexion, Mr. Driscoll was chief financial officer for Novavax ... team that secured more than $250 million through a ...
(Date:5/20/2013)... Researchers from the Southern University of ... back pain, and the acne causing P.acnes bacteria. Researchers believe ... bacteria seek out oxygen deprived location to seek shelter and ... P.acnes has the ability to live in the open joint ... spokesman for “ The best acne treatment ” explains why ...
(Date:5/20/2013)... Kitware, a leader in data visualization, today unveils a ... of hospital costs across the United States . The ... of “Medicare Provider Charge Data,” a dataset of pricing ... Centers for Medicare & Medicaid Services. , The wide ... the country has sparked considerable controversy; however, it is ...
Breaking Biology Technology:New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2Adult Acne Treatment, Probiotic Action Shares New Insight How Treating Acne May Help Reduce Body Pain 2Kitware Enables Interactive Exploration of CMS Medicare Data 2
... Sept. 24 Cyberonics, Inc. (Nasdaq: CYBX ) today ... JMP Securities 4th Annual Healthcare Focus Conference in New York on ... will host a webcast of the presentation live and by replay ... available for 90 days following the conference. Presentation slides will ...
... CAMBRIDGE, Mass., Sept. 24 Peptimmune, Inc. ("Peptimmune"), a ... a research and development collaboration with the Walter Reed Army ... (NMRC), Silver Spring, MD to evaluate the Company,s proprietary DEEP(TM) ... and point-of-care diagnostics. , , After ...
... YORK, Sept. 24 Reportlinker.com announces that a new market ... In Vitro Diagnostics in a ... , , http://www.reportlinker.com/p0119227/In-Vitro-Diagnostics-in-a-Recession-IVD-Market-Forecasts-Analysis-and-Success-Strategies.html ... commonly asserted that in vitro diagnostics is a recession-proof industry. ...
Cached Biology Technology:Cyberonics to Present at JMP Securities 4th Annual Healthcare Focus Conference 2Peptimmune to Collaborate on Dengue Virus Vaccine and Point-Of-Care Diagnostic With Two DOD Biomedical Research Facilities 2Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 2Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 3Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 4Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 5Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 6Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 7Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 8Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report 9
(Date:5/17/2013)... Bethesda, MD The Federation of American Societies for ... of National Institutes of Health (NIH) funding trends highlighting ... to support critical research. The FASEB analysis follows a ... Francis Collins, MD, PhD, who testified that the $1.6 ... to sequestration is "having a substantial impact on the ...
(Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Endocrine Society (ENDO) 95th Annual Meeting in San ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... ENDO 2013 Annual Meeting. , Awards are given ...
(Date:5/16/2013)... have used ancient shorelines to predict the stability of today,s ... high shoreline from three million years ago, for example ... thought to be evidence of a high sea level due ... led many scientists to think that if the world,s largest ... just the same in our modern, progressively warming world. ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2
... of the most devastating diseases in sub-Saharan Africa almost ... sickness, or trypanosomiasis, largely succumbed to heroic public health ... past several decades, because of post-colonial turmoil, the catastrophic ... the Democratic Republic of the Congo, the Sudan and ...
... annual migration time on Cape Cod again, the time of ... thousands. It's a sign of spring to the fishermen who ... here at the Marine Biological Laboratory (MBL), it triggers an ... world, who return here faithfully every summer to study the ...
... not only is vital to the immune system's ability to ... an unexpected location within the cell, causing researchers to rethink ... , Researchers at UT Southwestern Medical Center said their findings ... viral diseases such as the flu, hepatitis, West Nile virus ...
Cached Biology News:Compound might defeat African sleeping sickness, clinical trial beginning this month 2Compound might defeat African sleeping sickness, clinical trial beginning this month 3Compound might defeat African sleeping sickness, clinical trial beginning this month 4Gifts from the sea 2Gifts from the sea 3New protein vital for immune response is found in surprise location 2New protein vital for immune response is found in surprise location 3
Request Info...
CoverWell imaging chamber gasket with adhesive, one chamber, 20 mm diameter, 1.0 mm deep *set of 40* Cell Biology Imaging Tools and Accessories Microscope Slide Accessories...
Request Info...
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
Biology Products: